These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20708346)

  • 21. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer.
    Mell LK; Tiryaki H; Ahn KH; Mundt AJ; Roeske JC; Aydogan B
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1504-10. PubMed ID: 18640499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors influencing bowel sparing in intensity modulated whole pelvic radiotherapy for gynaecological malignancies.
    Georg P; Georg D; Hillbrand M; Kirisits C; Pötter R
    Radiother Oncol; 2006 Jul; 80(1):19-26. PubMed ID: 16766068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
    Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
    Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up.
    Kim DH; Wang-Chesebro A; Weinberg V; Pouliot J; Chen LM; Speight J; Littell R; Hsu IC
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1329-34. PubMed ID: 19409728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression.
    van de Bunt L; van der Heide UA; Ketelaars M; de Kort GA; Jürgenliemk-Schulz IM
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):189-96. PubMed ID: 15978745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
    Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
    Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix.
    Kaneyasu Y; Nagai N; Nagata Y; Hashimoto Y; Yuki S; Murakami Y; Kenjo M; Kakizawa H; Toyota N; Fujiwara H; Kudo Y; Ito K
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):369-77. PubMed ID: 19735865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Locally advanced carcinoma of the cervix uteri (stage IIB-IIIB TNM-UICC): radiotherapy combined with simultaneous daily low-dose platinum. Phase II study].
    Micheletti E; La Face B; Bianchi E; Cagna E; Sartori E
    Radiol Med; 1996 May; 91(5):628-34. PubMed ID: 8693131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
    Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
    Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer.
    Dubay RA; Rose PG; O'Malley DM; Shalodi AD; Ludin A; Selim MA
    Gynecol Oncol; 2004 Jul; 94(1):121-4. PubMed ID: 15262129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High control rate for lymph nodes in cervical cancer treated with high-dose radiotherapy using helical tomotherapy.
    Kim YJ; Kim JY; Yoo SH; Min BJ; Chung KZ; Seo SS; Kang SB; Lim MC; Hwang JH; Yoo HJ; Park SY
    Technol Cancer Res Treat; 2013 Feb; 12(1):45-51. PubMed ID: 22905806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
    Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
    Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome.
    Beriwal S; Heron DE; Kim H; King G; Shogan J; Bahri S; Gerszten K; Lee J; Kelley J; Edwards RP
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1395-400. PubMed ID: 16442238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course of late rectal- and urinary bladder side effects after MRI-guided adaptive brachytherapy for cervical cancer.
    Georg P; Boni A; Ghabuous A; Goldner G; Schmid MP; Georg D; Pötter R; Dörr W
    Strahlenther Onkol; 2013 Jul; 189(7):535-40. PubMed ID: 23703404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer.
    Borowsky ME; Elliott KS; Pezzullo JC; Santoso P; Choi W; Choi K; Abulafia O
    Bull Cancer; 2005 Feb; 92(2):E19-24. PubMed ID: 15749639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.